Perioperative medicine & outcomes

Effect of Urine-guided Intraoperative Hydration on Incidence of Acute Kidney Injury after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei: A Randomized Trial

AnesthesiologyPublished Randomised controlled trial

Primary result · AKIResult — go to the resultRelative risk 0.55 95% CI 0.33–0.89

Authors' conclusion

In patients who underwent CRS and cisplatin-HIPEC for pseudomyxoma peritonei, intraoperative urine-guided hydration reduced postoperative AKI by more than 40% and was safe.

Study context

Population
Adults scheduled for cytoreductive surgery (CRS) and cisplatin-based hyperthermia intraperitoneal chemotherapy (HIPEC) for pseudomyxoma peritoneiall in ITT analysis
Participants
168 adults
Comparison
Urine-guided vs routine intraoperative hydration
  • Urine-guided hydrationn = 84
  • Routine hydrationn = 84reference
Primary endpoint
Incidence of acute kidney injury (AKI) (Kidney Disease Improving Global Outcome criteria)
Follow-up
Within 7 days after surgery

Primary result

AKI · within 7 days

Relative risk

0.55

95% CI 0.33–0.89

P = 0.012

Events by treatment group

Urine-guided hydration vs Routine hydration
RR 0.55 (95% CI 0.33–0.89); P = 0.012

As reported in the abstract

Further findings

OutcomeRoutine hydrationRR (95% CI)P value
AKI by urine criteria (subgroup)35.7%0.60 (0.36–0.99)P = 0.040

Safety

OutcomeUrine-guided hydrationRoutine hydrationRR (95% CI)P value
Major complications · within 30 days36.9%56.0%0.66 (0.47–0.92)P = 0.013

Adverse events

Did not differ between groups

Original publication

Effect of Urine-guided Intraoperative Hydration on Incidence of Acute Kidney Injury after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei: A Randomized Trial. Anesthesiology. Published 13 August 2025. doi:10.1097/aln.0000000000005711

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.